Legal Solutions to Support and Safeguard Global Product Launch

Get Help from Our Practice Groups Specialized in Pharma, Biotech, and Medical Devices

Learn More
Digital legal

TransPerfect Legal Solutions

Patent Translation & Foreign Filing Litigation Support

Patent Translation & Foreign Filing

We simplify the patent translation and global filing process with our suite of comprehensive solutions for patent-related needs. TLS’s dedicated project managers, expert patent specialists, and highly qualified linguist pool help reduce translation costs, agency fees, administrative burdens, and turnaround times—without sacrificing quality or service.

Learn More

Litigation Support

When it comes to investigations and litigation support, TLS helps mitigate the challenges associated with e-discovery, privacy, and information security, and provides visibility into the discovery management process.

Learn More

Achieve Greatness in the Global Regulatory Landscape

Today, global sponsors are consistently challenged to bring products to market faster while facing evolving regulations with increased scrutiny. With the language barriers and collaboration logistics of global operations, clinical trials must be managed carefully to avoid unexpected increases in cost, time, and compliance risk. Having a global partner like TransPerfect by your side helps you focus on what matters most: saving lives.

Artificial Intelligence in Life Sciences

Latest Developments Presented by Industry Leaders

Watch the Webinar ›

Improved Outcomes by the Numbers

Avoid challenges in bringing therapeutic products to market by protecting intellectual property and effectively navigating international legal matters.

  • Cut down high-volume data sets in multiple languages within stringent turnaround times
  • Rapidly collect, review, and produce discovery data from multiple custodians
  • Provide insights into potential threats and protect against data breaches
  • Translate and file a patent in 20 different countries
Learn More

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations involved in conducting clinical research.

XTalks | How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI

Medical Information (MI), Pharmacovigilance (PV) and Regulatory Affairs (RA) each play distinct but deeply interconnected roles in ensuring that therapeutics are safe, accurately labeled and compliantly communicated to healthcare professionals and patients. Yet in practice, the boundaries between these functions are rarely clean; a safety signal surfaced through an MI inquiry can trigger a PV investigation, which in turn may prompt a label update, a Risk Management ...

XTalks | How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI
Webinar

LifeSci Talks COA Series | Nothing Remains the Same: Why Measures Have to Evolve

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician at Vector Psychometric Group, to talk about why the measures we rely on are living things rather than fixed artifacts. ...
Blog

Regulatory Considerations for Paper COA Translations | What You Need to Know

Collecting data for a global clinical trial on paper COAs or managing a mixed-mode study that combines both paper and electronic formats means satisfying multiple regulatory bodies before a single patient enrolls. None of these entities operate on the same timeline or...
Blog

When "How Does the Patient Feel?" Became a Regulatory Question

For decades, clinical trials were built around things you could measure with a machine: tumor shrinkage on a scan, laboratory values, and disease progression. These hard, objective endpoints were the backbone of drug approval. The patient's own account of how they felt,...
Webinar

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects ...
Webinar

SSCPs Are Not Labeling: Compliant AI Processes for Reduced Cost & Turnaround

In this fireside chat, TransPerfect Medical Device's President Marc Miller sits down with Dr. Keith Morel, VP of Regulatory Compliance at Qserve, to unpack a critical question facing medical device manufacturers under MDR: can you reduce the translation review process for ...
Success Stories

Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero

Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the ...

Get Global Legal Support.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.